Abstract
Maternally inherited diabetes and deafness (MIDD), a mitochondrial disease first described in 1992, results from the mitochondrial DNA mutation and affects up to 1% of the patients with diabetes. This review discusses the biomedical mechanisms of MIDD patients; summarizes the recent improvement of clinical and genetic diagnosis of MIDD; outlines the advances of the clinical management of these patients and their families.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
DNA, Mitochondrial / genetics
-
Deafness / diagnosis*
-
Deafness / genetics
-
Deafness / physiopathology
-
Deafness / therapy
-
Diabetes Mellitus, Type 2 / diagnosis*
-
Diabetes Mellitus, Type 2 / genetics
-
Diabetes Mellitus, Type 2 / physiopathology
-
Diabetes Mellitus, Type 2 / therapy
-
Female
-
Humans
-
Mitochondrial Diseases
-
Molecular Diagnostic Techniques
-
Mutation
-
Pregnancy
Supplementary concepts
-
Noninsulin-dependent diabetes mellitus with deafness